Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




AACE 2009: Primary Hyperparathyroidism May Lead to Increased Cancer Rates
Link ID 16195
Title AACE 2009: Primary Hyperparathyroidism May Lead to Increased Cancer Rates
Url http://www.medscape.com/viewarticle/703794?src=rss
Description Patients with PHPT should be screened more often for cancer, study says Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Jun 4, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Novel Vaccine Reduces Risk for Breast Cancer RecurrenceNovel Vaccine Reduces Risk for Breast Cancer
  An experimental HER2-based peptide vaccine induced immunologic responses in breast cancer patients at high risk for relapse. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. No Screening for Bladder Cancer: Insufficient EvidenceNo Screening for Bladder Cancer: Insufficient
  The tests that are currently available, mainly focused on measuring blood in the urine, have a low positive predictive value. br / iMedscape Medical News/i
Category:   Articles > Hematology-Oncology


3. Does Inflammation Stoke Cancer Growth?Does Inflammation Stoke Cancer Growth?
  Investigations into the microenvironment of tumor cells suggest that aspects of inflammation promote tumor growth. But Dr. David Kerr finds a gap in our understanding of good and bad inflammation. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


4. Trastuzumab Benefit Seen Even in Small HER2-Positive Tumors
  Even though it is not routinely recommended, patients with small HER2-positive tumors might benefit from adjuvant therapy. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. ASCO 2009: Change Bortezomib Schedule in Myeloma
  In elderly patients with myeloma, changing bortezomib administration from a twice-weekly to a once-weekly infusion reduces serious neuropathy and is recommended by an expert. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS